BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25788542)

  • 1. Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
    Canet MJ; Merrell MD; Hardwick RN; Bataille AM; Campion SN; Ferreira DW; Xanthakos SA; Manautou JE; A-Kader HH; Erickson RP; Cherrington NJ
    Drug Metab Dispos; 2015 Jun; 43(6):829-35. PubMed ID: 25788542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.
    Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ
    Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.
    Manautou JE; de Waart DR; Kunne C; Zelcer N; Goedken M; Borst P; Elferink RO
    Hepatology; 2005 Nov; 42(5):1091-8. PubMed ID: 16250050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats.
    Villanueva SS; Ruiz ML; Ghanem CI; Luquita MG; Catania VA; Mottino AD
    Drug Metab Dispos; 2008 Mar; 36(3):475-80. PubMed ID: 18096675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.
    Ghanem CI; Ruiz ML; Villanueva SS; Luquita M; Llesuy S; Catania VA; Bengochea LA; Mottino AD
    Biochem Pharmacol; 2009 May; 77(10):1621-8. PubMed ID: 19426699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats.
    Ghanem CI; Ruiz ML; Villanueva SS; Luquita MG; Catania VA; Jones B; Bengochea LA; Vore M; Mottino AD
    J Pharmacol Exp Ther; 2005 Dec; 315(3):987-95. PubMed ID: 16109740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
    Canet MJ; Hardwick RN; Lake AD; Kopplin MJ; Scheffer GL; Klimecki WT; Gandolfi AJ; Cherrington NJ
    Drug Metab Dispos; 2012 Sep; 40(9):1817-24. PubMed ID: 22699396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
    Chen C; Hennig GE; Manautou JE
    Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.
    Dzierlenga AL; Clarke JD; Hargraves TL; Ainslie GR; Vanderah TW; Paine MF; Cherrington NJ
    J Pharmacol Exp Ther; 2015 Mar; 352(3):462-70. PubMed ID: 25512370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
    Hardwick RN; Fisher CD; Street SM; Canet MJ; Cherrington NJ
    Drug Metab Dispos; 2012 Mar; 40(3):450-60. PubMed ID: 22112382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.
    Barshop NJ; Capparelli EV; Sirlin CB; Schwimmer JB; Lavine JE
    J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):198-202. PubMed ID: 21240014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Adaptation to Therapeutic Doses of Acetaminophen: An Exploratory Study in Healthy Individuals.
    Maeda M; Tanaka R; Aso M; Sakamoto Y; Song I; Ochiai M; Saito Y; Maekawa K; Arakawa N; Ohno Y; Kumagai Y
    Clin Ther; 2020 Jul; 42(7):1276-1291.e1. PubMed ID: 32620339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
    Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD
    Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of taurine on biliary excretion and metabolism of acetaminophen in male hamsters.
    Lee JY; Jung DW; Park HA; Kim SJ; Chung JH; Moon CK; Kim YC
    Biol Pharm Bull; 2004 Nov; 27(11):1792-6. PubMed ID: 15516725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethynylestradiol increases expression and activity of rat liver MRP3.
    Ruiz ML; Villanueva SS; Luquita MG; Vore M; Mottino AD; Catania VA
    Drug Metab Dispos; 2006 Jun; 34(6):1030-4. PubMed ID: 16554369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
    Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Goedken MJ; Cherrington NJ
    Drug Metab Dispos; 2015 Feb; 43(2):266-72. PubMed ID: 25488932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary Elimination of Pemetrexed Is Dependent on Mrp2 in Rats: Potential Mechanism of Variable Response in Nonalcoholic Steatohepatitis.
    Dzierlenga AL; Clarke JD; Klein DM; Anumol T; Snyder SA; Li H; Cherrington NJ
    J Pharmacol Exp Ther; 2016 Aug; 358(2):246-53. PubMed ID: 27233293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet.
    Mannery YO; Ziegler TR; Park Y; Jones DP
    J Pharmacol Exp Ther; 2010 Jun; 333(3):948-53. PubMed ID: 20207720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pharmacokinetic profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either glycyrrhizin, silibinin or spironolactone in rat.
    Xu R; Wang Q; Zhang J; Zang M; Liu X; Yang J
    Xenobiotica; 2014 Jun; 44(6):541-6. PubMed ID: 24251357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.